European Network of Paediatric at the European Medicines Agency (EMA)
A network of research networks, investigators and centres with recognised expertise in performing clinical studies in children. Abbreviated as Enpr-EMA.
Information, see European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA).
The RETICS “Red SAMID” is a Enpr-EMA's member, Category 1.
Enpr-EMA's members must fulfil the requirements laid down in a set of six recognition criteria:
Enpr-EMA's main objective is to facilitate studies in order to increase availability of medicinal products authorised for use in the paediatric population, by:
Enpr-EMA works by allowing networking and collaboration with members from within and outside the European Union (EU), including academia and the pharmaceutical industry. The network does not perform clinical trials or fund studies or research or decide on areas for paediatric research, as this is the responsibility of Member States, the European Commission or each individual member organisation..
The European Medicines Agency (EMA) is responsible for providing secretarial support to the activities of the network ensuring exchange of information between the network partners, as well as providing information to external partners and stakeholders.
Enpr-EMA regularly publishes newsletters to provide updates on its activities to its members and stakeholders:
Plataforma “Spanish Clinical Research Network (SCReN)”
The SAMID Network has joined samid ties with the SCReN-ISCIII national platform in the pediatric environment.
SCReN is a Platform that groups together 29 Clinical Research and Clinical Trial Units (UICECs) from 11 autonomous communities. It is a non-profit association, interwoven in a scientific community, in which decisions about medical practice are made, based on evidence obtained from quality clinical research. Information and the web www.scren.es
The objectives of this program are to achieve an advanced level of technical competence of the processes related to the development and management of clinical research, ensuring compliance with legal requirements and competence of the researchers involved in the platform's studies on methodological aspects and GCPs, etc.
To achieve this objective SCRen collaborates with researchers, cooperative groups and Research Institutes, etc. to conduct independent and multicentre clinical trials and studies. This collaboration includes networking and providing direct advice to help with the management and coordination of national or European (ECRIN) studies.
For this purpose, the SCRen Platform links various internal Programs:
REGULATION AND MONITORING PROGRAM (MRP)
PHARMACOVIGILANCE PROGRAM (PVP)
METHODOLOGY, BIOSTATISTICS AND DATA MANAGEMENT PROGRAM (MBDMP)
COORDINATION AND TRAINING PROGRAM (PCYF)
SCRen channels the flow of knowledge and homogenizes the work process in the associated sites and thus increases competitiveness and promotes the integration of Spanish research throughout Europe.
Red Española de Ensayos Clínico Pediátricos “RECLIP”
The SAMID Network i the RECLIP Network.
RECLIP is the Spanish Pediatric Clinical Trials Network with the main objective of providing a fully developed and professionalized network of top national clinical trial units, ensuring an environment and an appropriate infrastructure for conducting safe and effective pediatric clinical trials.
RECLIP aims to work as the national reference hub for any international or national initiative dealing with pediatric clinical trials.
RECLIP conducts pediatric clinical drug trials in a variety of therapeutic areas, including but not limited to vaccines, infectious diseases, cardiovascular diseases, cancer, gastroenterology, respiratory diseases, endocrinology, neonatology, and medical devices.
RECLIP is created on the basis of the clinical strength of major pediatric hospitals, combined with primary health care centers and thematic research networks that develop relevant activity in pediatric clinical research.
International organization for the dissemination of scientific knowledge in the area of perinatology based in Austria.
Grupos Clínicos Afiliados
We have a collaboration agreement with 25 hospitals, Dr. Valls's initiative.
Unidades Neonatales - proyecto NeoKisses y INBERBAC-Neo
With more than 40 neonatal units. We keep you informed of initiatives to be able to collaborate. link
Innovatice Medicines Initiative
Belonging to the European Commission. WEB
EFCNI - European Foundation for Care of Newborn Infants
As experts, in the creation of reports and guides. Ver su web.